title: [Devices for the safe performance of self-injection of interferon therapy for chronic hepatitis C].
abstract: Long-term interferon therapy is an alternative therapy for patients with chronic hepatitis C who can not tolerate to the combination of pegylated interferon and ribavirin. In 2005, self-injection of interferon for chronic hepatitis C was covered by public health insurance in Japan making the long-term interferon therapy easier to perform. For the safe performance of self-injection, education about knowledge on various adverse effects of interferon, training for actual performance of self-injection, and close contact between the patients and doctors are indispensable. In this review, we briefly summarized why self-injection is needed and how the training for safe self-injection of interferon should be performed.
authors.affiliation: Department of Medicine and Clinical Oncology, Graduate School of Medicine Chiba University.
authors.forename: Tomoko
authors.initials: T
authors.lastname: Kurihara
authors.forename: Rintaro
authors.initials: R
authors.lastname: Mikata
authors.forename: Osamu
authors.initials: O
authors.lastname: Yokosuka
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007273:Injections, Intramuscular; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000009:adverse effects; D010353:Patient Education as Topic; D011092:Polyethylene Glycols / Q000008:administration & dosage* / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011994:Recombinant Proteins; D012646:Self Administration
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a